Marker Therapeutics Inc (MRKR) — Strategic Asset Allocation Index
Marker Therapeutics Inc (MRKR) has a Strategic Asset Allocation Index of 107.0% as of March 2023. Strategic assets (PP&E of $17.03 Million plus long-term investments of $-) total $17.03 Million, measured against net assets of $15.91 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Marker Therapeutics Inc Strategic Asset Allocation Index (2002–2021)
This chart shows how Marker Therapeutics Inc's Strategic Asset Allocation Index has evolved across 5 annual periods from 2002 to 2021. As of March 2023, the index stands at 107.0%, representing strategic assets of $17.03 Million against net assets of $15.91 Million USD. Explore MRKR cash generation efficiency to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Marker Therapeutics Inc (2002–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Marker Therapeutics Inc from 2002 to 2021, covering 5 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Marker Therapeutics Inc (MRKR) total market value.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 50.4% | $22.15 Million | $22.15 Million | $- | $43.99 Million | ▲ +25.5 pp |
| 2020 | 24.8% | $6.79 Million | $6.79 Million | $- | $27.34 Million | ▲ +22.8 pp |
| 2019 | 2.0% | $872.70K | $872.70K | $- | $44.09 Million | ▲ +1.7 pp |
| 2018 | 0.2% | $147.67K | $147.67K | $- | $59.34 Million | ▼ -23.8 pp |
| 2002 | 24.0% | $112.00K | $112.00K | $- | $465.83K | — |